US Patent Issued to National University of Singapore, BioLamina on July 14 for "Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221" (Swedish, Singaporean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,680,078, issued on July 14, was assigned to National University of Singapore (Singapore) and BioLamina AB (Sundyberg, Sweden).

"Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221" was invented by Karl Tryggvason (Singapore), Yan Wen Yap (Singapore), Kristian Tryggvason (Sundbyberg, Sweden) and Yi Sun (Sundbyberg, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes methods of differentiating cardiomyocyte progenitor cells and mature cardiomyocyte cells from pluripotent stem cells. The methods may include differentiating pluri...